BridgeBio bounces back? Phase 2 readout provides hope for approval of drug to rebalance calcium levels

After a series of unfortunate events for BridgeBio Pharma, the biotech may be on a new upward trajectory as it unveiled positive data from 13 patients taking a drug to treat low calcium levels.